SYNTHESIS AND BIOLOGICAL-ACTIVITY OF CERTAIN 6-SUBSTITUTED AND 2,6-DISUBSTITUTED 2'-DEOXYTUBERCIDINS PREPARED VIA THE STEREOSPECIFIC SODIUM-SALT GLYCOSYLATION PROCEDURE

被引：46

作者：

COTTAM, HB ^{[1
]}

KAZIMIERCZUK, Z ^{[1
]}

GEARY, S ^{[1
]}

MCKERNAN, PA ^{[1
]}

REVANKAR, GR ^{[1
]}

ROBINS, RK ^{[1
]}

机构：

[1] BRIGHAM YOUNG UNIV,DEPT CHEM,CANC RES CTR,PROVO,UT 84602

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 1985年 / 28卷 / 10期

关键词：

D O I：

10.1021/jm00148a015

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：1461 / 1467

页数：7

共 44 条

[1] ENHANCEMENT OF BIOLOGICAL-ACTIVITY OF ADENOSINE-ANALOGS BY ADENOSINE-DEAMINASE INHIBITOR 2'-DEOXYCOFORMYCIN [J].

ADAMSON, RH ;

ZAHAREVITZ, DW ;

JOHNS, DG .

PHARMACOLOGY, 1977, 15 (01) :84-89

[2] 2-DEOXY-D-ERYTHRO-PENTOSE .9. SOME RELATIONSHIPS AMONG ROTATIONS OF ACYLATED ALDOPENTOSES, ALDOPENTOSYL HALIDES, AND ANHYDROPENTITOLS [J].

BHATTACHARYA, AK ;

NESS, RK ;

FLETCHER, HG .

JOURNAL OF ORGANIC CHEMISTRY, 1963, 28 (02) :428-&

[3] ON MODE OF ACTION OF 7-DEAZA-ADENOSINE (TUBERCIDIN) [J].

BLOCH, A ;

LEONARD, RJ ;

NICHOL, CA .

BIOCHIMICA ET BIOPHYSICA ACTA, 1967, 138 (01) :10-+

[4] DEOXYCYTIDINE KINASE-MEDIATED TOXICITY OF DEOXYADENOSINE ANALOGS TOWARD MALIGNANT HUMAN-LYMPHOBLASTS INVITRO AND TOWARD MURINE L1210 LEUKEMIA INVIVO [J].

CARSON, DA ;

WASSON, DB ;

KAYE, J ;

ULLMAN, B ;

MARTIN, DW ;

ROBINS, RK ;

MONTGOMERY, JA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (11) :6865-6869

[5] SYNTHESIS AND BIOLOGICAL-ACTIVITY OF SELECTED 2,6-DISUBSTITUTED-(2-DEOXY-ALPHA-D-ERYTHRO-PENTOFURANOSYL) AND -BETA-D-ERYTHRO-PENTOFURANOSYL)PURINES [J].

CHRISTENSEN, LF ;

BROOM, AD .

JOURNAL OF MEDICINAL CHEMISTRY, 1972, 15 (07) :735-+

[6] PYRROLO[2,3-D]PYRIMIDINES [J].

DAVOLL, J .

JOURNAL OF THE CHEMICAL SOCIETY, 1960, (JAN) :131-138

[7] Article on the formation of pyrimidin rings, II. Announcement [J].

Foldi, Z ;

von Fodor, G ;

Demjen, I ;

Szekeres, H ;

Halmos, I .

BERICHTE DER DEUTSCHEN CHEMISCHEN GESELLSCHAFT, 1942, 75 :755-763

[8]

FUKUKAWA K, 1983, CHEM PHARM BULL, V31, P1842

[9]

GLAZER RI, 1984, MOL PHARMACOL, V24, P509

[10]

Goodman L., 1974, BASIC PRINCIPLES NUC, V1, P93

← 1 2 3 4 5 →